<code id='88EA53A42F'></code><style id='88EA53A42F'></style>
    • <acronym id='88EA53A42F'></acronym>
      <center id='88EA53A42F'><center id='88EA53A42F'><tfoot id='88EA53A42F'></tfoot></center><abbr id='88EA53A42F'><dir id='88EA53A42F'><tfoot id='88EA53A42F'></tfoot><noframes id='88EA53A42F'>

    • <optgroup id='88EA53A42F'><strike id='88EA53A42F'><sup id='88EA53A42F'></sup></strike><code id='88EA53A42F'></code></optgroup>
        1. <b id='88EA53A42F'><label id='88EA53A42F'><select id='88EA53A42F'><dt id='88EA53A42F'><span id='88EA53A42F'></span></dt></select></label></b><u id='88EA53A42F'></u>
          <i id='88EA53A42F'><strike id='88EA53A42F'><tt id='88EA53A42F'><pre id='88EA53A42F'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:21
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          Sanofi strikes deal with Novavax, boosting the vaccine maker
          Sanofi strikes deal with Novavax, boosting the vaccine maker

          NICOLASMAETERLINCK/BELGAMAG/AFPviaGettyImagesLONDON—Novavax,thebeleagueredmakerofaCovid-19vaccine,ju

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

          AdobeItshouldbehard—exceedinglyhard—toobtainthesyntheticDNAneededtorecreatethevirusthatcausedthedead